Cyclerion Therapeutics Inc
NASDAQ:CYCN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cyclerion Therapeutics Inc
NASDAQ:CYCN
|
US |
|
Equinox Gold Corp
TSX:EQX
|
CA |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
Eurofins Scientific SE
PAR:ERF
|
LU |
|
R
|
Royal Caribbean Cruises Ltd
BMV:RCL
|
US |
|
Veritone Inc
NASDAQ:VERI
|
US |
|
Daiki Aluminium Industry Co Ltd
TSE:5702
|
JP |
|
D
|
Diageo PLC
PAR:DGE
|
UK |
|
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
Tate & Lyle PLC
LSE:TATE
|
UK |
|
Prima Alloy Steel Universal Tbk PT
IDX:PRAS
|
ID |
|
LHN Ltd
SGX:41O
|
SG |
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
Tourmaline Bio Inc
NASDAQ:TRML
|
US |
|
Oceania Healthcare Ltd
ASX:OCA
|
NZ |
Intrinsic Value
The intrinsic value for
Cyclerion Therapeutics Inc (CYCN) under the Base Case is hidden
USD.
Compared with the current market price of 3.06 USD, the stock appears hidden
.
CYCN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CYCN usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cyclerion Therapeutics Inc.
The intrinsic value for
Cyclerion Therapeutics Inc (CYCN) under the Base Case is hidden USD.
Compared with the current market price of 3.06 USD, the stock appears hidden.